The **Cervical Screening (HPV DNA Qualitative Detection + LBC)** test is a combined diagnostic procedure used to detect high-risk strains of the Human Papillomavirus (HPV) and examine cervical cells for abnormalities. The HPV DNA test identifies the presence of viral genetic material, while Liquid-Based Cytology (LBC) evaluates cell changes that may indicate precancerous or cancerous conditions. Doctors recommend this screening to help prevent cervical cancer, monitor women’s reproductive health, and ensure early detection of potential risks for timely treatment.
It helps prevent cervical cancer by detecting HPV infections and early cell changes before they progress.
It indicates the presence of high-risk HPV strains that may cause cervical cancer.
It means no high-risk HPV was detected, lowering the risk of cervical cancer.
No, it detects HPV and abnormal cells, which are precursors to cancer.
Yes, it can be performed safely, though technique may be adjusted for comfort.
Certainly, many HPV infections resolve naturally, but persistent infections require monitoring.
Yes, smoking, multiple sexual partners, and poor immunity increase HPV risk.
Yes, but routine screening usually begins at age 21.
...
Didn't recieved OTP Yet? Resend OTP